Skip to main content
CVS logo

CVS · CVS HEALTH Corp

Track CVS — free
$97.16 +2.17 (+2.28%) At close · Aug 14
Market Cap
$124.26B
Shares
1.28B

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
David Joyner $21,214,084
J. David Joyner $21,214,084
Prem S. Shah $13,379,210
Prem Shah $13,379,210
Steven H. Nelson $11,587,110
Tilak Mandadi $10,977,716
Brian O. Newman $9,420,508
Thomas F. Cowhey $6,715,138
Fiscal 2024
Executive Total
Karen Lynch $23,431,466
J. David Joyner $17,808,792
David Joyner $17,808,792
Prem S. Shah $13,265,855
Prem Shah $13,265,855
Tilak Mandadi $11,361,343
Thomas F. Cowhey $7,644,364
Heidi B. Capozzi $6,850,748
Fiscal 2023
Executive Total
Karen Lynch $21,615,034
Shawn Guertin $12,494,134
Samrat S. Khichi $11,886,503
Tilak Mandadi $8,881,845
Prem S. Shah $8,582,366
Prem Shah $8,582,366
Thomas F. Cowhey $4,579,937
Fiscal 2022
Executive Total
Karen Lynch $21,317,055
Shawn Guertin $14,630,713
Tilak Mandadi $13,991,858
Alan Lotvin $10,983,750
Prem Shah $9,015,218
Prem S. Shah $9,015,218
Fiscal 2021
Executive Total
Karen Lynch $20,388,412
Jonathan C. Roberts $15,354,581
Shawn Guertin $14,339,230
Alan Lotvin $11,011,560
Eva Boratto $9,885,690
Troyen A. Brennan $8,793,264
Larry Merlo $3,784,072
Fiscal 2020
Executive Total
Larry Merlo $23,043,822
Jonathan C. Roberts $13,001,212
Karen Lynch $11,307,916
Eva Boratto $8,921,153
Alan Lotvin $7,472,175
Fiscal 2019
Executive Total
Larry Merlo $36,451,749
Thomas M. Moriarty $23,154,934
Jonathan C. Roberts $15,048,380
Derica W. Rice $10,626,219
Eva Boratto $9,564,223
Fiscal 2018
Executive Total
Larry Merlo $21,939,098
Jonathan C. Roberts $16,066,968
Thomas M. Moriarty $10,983,856
Eva Boratto $6,972,421
Fiscal 2017
Executive Total
Larry Merlo $12,252,864
Jonathan C. Roberts $6,882,764
Thomas M. Moriarty $4,512,554

Executive changes

Person Change Filed
John E. Gallina Appointed 2026-03-19
Amy L. Compton-Phillips Appointed 2025-04-08
Brian O. Newman Appointed 2025-04-08
Doug Shulman Appointed 2024-11-18
Guy Sansone Appointed 2024-11-18
Larry Robbins Appointed 2024-11-18
Leslie Norwalk Appointed 2024-11-18
Steven H. Nelson Appointed 2024-11-06
Prem S. Shah Appointed 2024-11-06
Roger N. Farah Appointed 2024-10-18
Karen S. Lynch Resigned 2024-10-18
Karen S. Lynch Resigned 2024-10-18
J. David Joyner Appointed 2024-10-18
J. David Joyner Appointed 2024-10-18
Thomas F. Cowhey Appointed 2024-01-05
Thomas F. Cowhey Appointed 2023-10-16
Michael F. Mahoney Appointed 2023-09-21
J. Scott Kirby Appointed 2023-07-20
J. David Joyner Appointed 2023-01-23
Jeffrey R. Balser, M.D., Ph.D. Appointed 2022-09-13
Key facts CIK 64803 CUSIP 126650100 13F (30d) 1803 filings 1737 filers Visit website Investor relations